Ezetimibe

Resumen

Alternativas con registro en Colombia

• Omega-3-trigliceridos · costo anual estimado $ 2.569.600
• Lomitapida · costo anual estimado $ 6.720.257.360
• Evolocumab · costo anual estimado $ 8.660.355
• Alirocumab · costo anual estimado $ 6.259.750
• Inclisirán · costo anual estimado $ 7.834.725

Estudios clínicos principales

• A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients
  Fase 3 · 2007 · 1.289 participantes · Organon and Co · NCT00535405 · PubMed 21029821
• Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)
  Fase 3 · 2009 · 138 participantes · Organon and Co · NCT00867165 · PubMed 25841542
• A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or
  Fase 3 · 2001 · 769 participantes · Organon and Co · NCT03882905 · PubMed 15811480 · PubMed 12423708
• Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular R
  Fase 3 · 2000 · 621 participantes · Organon and Co · NCT03867318 · PubMed 15389231

Enfermedades relacionadas

• Colesterol y triglicéridos altos

Fuentes

• Etiqueta FDA (DailyMed): Ezetimibe and Simvastatin
• EMA: Nustendi